BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29481474)

  • 1. Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.
    Huang R; Zhang X; Sophia S; Min Z; Liu X
    Anticancer Drugs; 2018 Apr; 29(4):364-370. PubMed ID: 29481474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas.
    Campos B; Bermejo JL; Han L; Felsberg J; Ahmadi R; Grabe N; Reifenberger G; Unterberg A; Herold-Mende C
    Cancer Sci; 2011 Feb; 102(2):387-92. PubMed ID: 21143702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression.
    Müller BM; Jana L; Kasajima A; Lehmann A; Prinzler J; Budczies J; Winzer KJ; Dietel M; Weichert W; Denkert C
    BMC Cancer; 2013 Apr; 13():215. PubMed ID: 23627572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expressions of HDAC1 and HDAC2 in prostate cancer and their clinical implications].
    Yin CK; Fu Q
    Zhonghua Nan Ke Xue; 2013 Aug; 19(8):699-703. PubMed ID: 24010203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma.
    Wang H; Kohashi K; Yoshizumi T; Okumura Y; Tanaka Y; Shimokawa M; Iwasaki T; Aishima S; Maehara Y; Oda Y
    Hum Pathol; 2017 Jun; 64():69-75. PubMed ID: 28411180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy.
    Zhao H; Yu Z; Zhao L; He M; Ren J; Wu H; Chen Q; Yao W; Wei M
    Jpn J Clin Oncol; 2016 Oct; 46(10):893-902. PubMed ID: 27432453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of HDAC1 and HDAC2 during cerebellar cortical development.
    Yoo JY; Larouche M; Goldowitz D
    Cerebellum; 2013 Aug; 12(4):534-46. PubMed ID: 23436026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
    Karube K; Niino D; Kimura Y; Ohshima K
    Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma.
    Wu LM; Yang Z; Zhou L; Zhang F; Xie HY; Feng XW; Wu J; Zheng SS
    PLoS One; 2010 Dec; 5(12):e14460. PubMed ID: 21206745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A.
    Wisnieski F; Calcagno DQ; Leal MF; Chen ES; Gigek CO; Santos LC; Pontes TB; Rasmussen LT; Payão SL; Assumpção PP; Lourenço LG; Demachki S; Artigiani R; Burbano RR; Smith MC
    Tumour Biol; 2014 Jul; 35(7):6373-81. PubMed ID: 24668547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of histone deacetylase 1 and metastasis-associated protein 1 as prognostic factors in colon cancer.
    Higashijima J; Kurita N; Miyatani T; Yoshikawa K; Morimoto S; Nishioka M; Iwata T; Shimada M
    Oncol Rep; 2011 Aug; 26(2):343-8. PubMed ID: 21617866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and functional characterization of recombinant human HDAC1 and HDAC3.
    Li J; Staver MJ; Curtin ML; Holms JH; Frey RR; Edalji R; Smith R; Michaelides MR; Davidsen SK; Glaser KB
    Life Sci; 2004 Apr; 74(22):2693-705. PubMed ID: 15043985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC.
    Quint K; Agaimy A; Di Fazio P; Montalbano R; Steindorf C; Jung R; Hellerbrand C; Hartmann A; Sitter H; Neureiter D; Ocker M
    Virchows Arch; 2011 Aug; 459(2):129-39. PubMed ID: 21713366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.
    Mithraprabhu S; Kalff A; Chow A; Khong T; Spencer A
    Epigenetics; 2014 Nov; 9(11):1511-20. PubMed ID: 25482492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population.
    Ler SY; Leung CH; Khin LW; Lu GD; Salto-Tellez M; Hartman M; Iau PT; Yap CT; Hooi SC
    Oncol Rep; 2015 Nov; 34(5):2238-50. PubMed ID: 26352599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts.
    Horiuchi M; Morinobu A; Chin T; Sakai Y; Kurosaka M; Kumagai S
    J Rheumatol; 2009 Aug; 36(8):1580-9. PubMed ID: 19531758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast.
    Seo J; Min SK; Park HR; Kim DH; Kwon MJ; Kim LS; Ju YS
    J Breast Cancer; 2014 Dec; 17(4):323-31. PubMed ID: 25548579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Histone Deacetylase Inhibition on the Expression of Multidrug Resistance-associated Protein 2 in a Human Placental Trophoblast Cell Line.
    Duan HY; Ma D; Zhou KY; Wang T; Zhang Y; Li YF; Wu JL; Hua YM; Wang C
    Chin Med J (Engl); 2017 Jun; 130(11):1352-1360. PubMed ID: 28524836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma.
    Adams H; Fritzsche FR; Dirnhofer S; Kristiansen G; Tzankov A
    Expert Opin Ther Targets; 2010 Jun; 14(6):577-84. PubMed ID: 20415600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.